Recent advances of immunohistochemistry for diagnosis of renal tumors

Pathology International

Volumn 63, Issue 8, 2013, Pages 381-390

  Kuroda, Naoto ^a   Tanaka, Azusa ^a   Ohe, Chisato ^b   Nagashima, Yoji ^c  

^a KOCHI RED CROSS HOSPITAL   (Japan)

^b KANSAI MEDICAL UNIVERSITY HOSPITAL   (Japan)

^c YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ALK; Immunohistochemistry; Renal tumors; TFE3; TFEB

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; ALPHA SMOOTH MUSCLE ACTIN; CALCIUM OXALATE; CARBONATE DEHYDRATASE IX; CATHEPSIN K; CD57 ANTIGEN; CD82 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 7; EPITHELIAL MEMBRANE ANTIGEN; MELAN A; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MONOCLONAL ANTIBODY HMB 45; PROTEIN P63; STEM CELL FACTOR RECEPTOR; THROMBOMODULIN; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR PAX2; TRANSCRIPTION FACTOR PAX8; TROPOMYOSIN; TROPOMYOSIN 3; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; VINCULIN;

CANCER DIAGNOSIS; CHROMOSOME 3P; CHROMOSOME TRANSLOCATION; CLEAR CELL PAPILLARY RENAL CELL CARCINOMA; COLLECTING DUCT CARCINOMA OF BELLINI; DIALYSIS RELATED RENAL CELL CARCINOMA; DIFFERENTIAL DIAGNOSIS; GENE FUSION; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC TRAIT; HEMODIALYSIS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; KIDNEY ADENOMA; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY HEMANGIOMYOLIPOMA; KIDNEY METASTASIS; MEDULLARY CARCINOMA; METANEPHRIC ADENOMA; MUCINOUS TUBULAR AND SPINDLE CELL CARCINOMA; MULTILOCULAR CYSTIC RENAL CELL CARCINOMA; ONCOCYTOMA; PAPILLARY CARCINOMA; PAPILLARY RENAL CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSAMMOMA BODY; RENAL ONCOCYTOMA; REVIEW; SPINDLE CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; TRANSLOCATION ASSOCIATED RENAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ALK; IMMUNOHISTOCHEMISTRY; RENAL TUMORS; TFE3; TFEB;

CARCINOMA, RENAL CELL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84882653234     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12080     Document Type: Review

References (58)

1. Nagashima Y, Kuroda N, Yao M. Transition of organizational category on renal cancer. Jpn J Clin Oncol 2013; 43: 233-242.
2. Kuroda N, Tanaka A. Recent advances of renal tumor classification. Med Mol Morphol 2013 DOI:10.1007/s00795-013-0033-0.
3. Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions. A sensitive and specific immunohistochemical assay. Am J Surg Pathol 2003; 27: 750-761.
4. Kuroda N, Mikami S, Pan CC etal. Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect. Histol Histopathol 2012; 27: 133-140.
5. Macher-Goeppinger S, Roth W, Wagener N etal. Molecular heterogeneity of TFE3 activation in renal cell carcinomas. Mod Pathol 2012; 25: 308-315.
6. Argani P, Lae M, Hutchinson B etal. Renal carcinomas with the t(6;11)(p21;q12). Clinicopathologic features and demonstration of the specific Alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA-PCR. Am J Surg Pathol 2005; 29: 230-240.
7. Kuroda N, Tanaka A, Sasaki N etal. Review of renal carcinoma with t(6;11)(p21;q12) with focus on clinical and pathobiological aspects. Histol Histopathol 2013; 28: 685-690.
8. Debelenko LV, Raimondi SC, Daw N etal. Renal cell carcinoma with novel VCL-ALK fusion: New representative ALK-associated tumor spectrum. Mod Pathol 2011; 24: 430-442.
9. Mariño-Enríquez A, Ou WB, Weldon CB, Fletcher JA, Pérez-Atayde AR. ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosomes Cancer 2011; 50: 146-153.
10. Sugawara E, Togashi Y, Kuroda N etal. Identification of anaplastic lymphoma kinase fusions in renal cancer: Large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method. Cancer 2012; 118: 4427-4436.
11. Sukov WR, Hodge JC, Lohse CM etal. ALK alterations in adult renal cell carcinomas: Frequency, clinicopathologic features and outcome in a large series of consecutively treated patients. Mod Pathol 2012; 25: 1516-1525.
12. Tickoo SK, dePeralta-Venturina MN, Harik LR etal. Spectrum of epithelial neoplasms in end-stage renal disease: An experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006; 30: 141-153.
13. Pan CC, Chen YJ, Chang LC, Chang YH, Ho DMT. Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma. Histopathology 2009; 55: 145-153.
14. Bhatnagar R, Alexiev BA. Renal cell carcinoma in end-stage kidneys: A clinicopathological study with emphasis on clear-cell papillary renal-cell carcinoma and acquired cystic kidney disease-associated carcinoma. Int J Surg Pathol 2012; 20: 19-28.
15. Kuroda N, Ohe C, Mikami S etal. Review of acquired cystic disease-associated renal cell carcinoma with focus on pathobiological aspects. Histol Histopathol 2011; 26: 1215-1218.
16. Inoue T, Matuura K, Yoshimoto T etal. Genomic profiling of renal cell carcinoma in patients of end-stage renal disease. Cancer Sci 2012; 103: 569-575.
17. Gobbo S, Eble JN, Grignon DJ etal. Clear cell papillary renal cell carcinoma. A distinct histopathologic and molecular genetic entity. Am J Surg Pathol 2008; 32: 1239-1245.
18. Yang XJ, Zhou M, Hes O etal. Tubulocystic carcinoma of the kidney. Clinicopathologic and molecular genetic characterization. Am J Surg Pathol 2008; 32: 177-187.
19. Zhou M, Yang XJ, Lopez JI etal. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: Implications for pathologic classification. Am J Surg Pathol 2009; 33: 1840-1849.
20. Kim MK, Kim S. Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Appl Immunohistochem Mol Morphol 2002; 10: 332-338.
21. Zhou M, Roma A, Magi-Galluzzi C. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasm. Clin Lab Med 2005; 25: 247-257.
22. Skinnider BF, Amin MB. An immunohistochemical approach to the differential diagnosis of renal tumors. Sem Diagn Pathol 2005; 22: 51-68.
23. Troung LD, Shen SS. Immunohisotchemical diagnosis of renal neoplasm. Arch Pathol Lab Med 2011; 135: 92-109.
24. Shen SS, Troung LD, Scarpelli M, Lopez-Beltran A. Role of immunohistochemistry in diagnosing renal neoplasms. When is it really useful? Arch Pathol Lab Med 2012; 136: 410-417.
25. Skinnider B, Folpe AL, Hennigar RA etal. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue. Potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg Pathol 2005; 29: 747-754.
26. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 2000; 24: 203-210.
27. Kuehn A, Paner GP, Skinnider BF etal. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: Diagnostic and histogenetic implications. Am J Surg Pathol 2007; 31: 1528-1533.
28. Shen SS, Krishna B, Chirala R, Amato RJ, Troung LD. Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms. Mod Pathol 2005; 18: 933-940.
29. Genega EM, Ghbremichael M, Najarian R etal. Carbonic anhydrase IX expression in renal neoplasms. Correlation with tumor type and grade. Am J Clin Pathol 2010; 134: 873-879.
30. Williamson SR, Halat S, Eble JN etal. Multilocular cystic renal cell carcinoma. Similarities and differences in immunoprofile compared with clear cell renal cell carcinoma. Am J Surg Pathol 2012; 36: 1425-1433.
31. Kuroda N, Ohe C, Mikami S etal. Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 2012; 27: 969-974.
32. Kuroda N, Toi M, Hiroi M, Enzan H. Review of papillary renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 2003; 18: 487-494.
33. Szponar A, Yusenko MV, Kuiper R, van Kessel AG, Kovacs G. Genomic profiling of papillary renal cell tumours identifies small regions of DNA alterations: A possible role of HNF1B in tumour development. Histopathology 2011; 58: 934-943.
34. Tretiakova MS, Sahoo S, Takahashi M etal. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol 2004; 28: 69-76.
35. Paner GP, Srigley JR, Radhakrishnan A etal. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney. Significant immunophenotypic overlap warrants diagnostic caution. Am J Surg Pathol 2006; 30: 13-19.
36. Mazal PR, Stichenwirth M, Koller A, Blach S, Haitel B, Sunani M. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: A tissue microarray study. Mod Pathol 2005; 18: 535-540.
37. Molinié V, Balaton A, Rotman S etal. Alpha-methyl CoA racemase expression in renal cell carcinomas. Hum Pathol 2006; 37: 698-703.
38. Lagner C, Ratschek M, Rehak P, Schips L, Zigueuner R. CD10 expression is a diagnostic and prognostic marker in renal malignancies. Histopathology 2004; 45: 460-467.
39. Olgac S, Hutchinson B, Tickoo SK, Reuter VE. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma. Mod Pathol 2006; 19: 218-224.
40. Kuroda N, Toi M, Hiroi M, Enzan H. Review of chromophobe renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 2003; 18: 165-171.
41. Martignoni G, Pea M, Chillossi M etal. Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod Pathol 2001; 14: 760-767.
42. Abrahams NA, MacLennan GT, Khoury JD etal. Chromophobe renal cell carcinoma: A comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology 2004; 45: 593-602.
43. Yusenko MV, Kovacs G. Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma. Histopathology 2009; 55: 687-695.
44. Pan CC, Chen PCH, Ho DMT. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: An immunohistochemical analysis of 328 cases. Histopathology 2004; 45: 452-459.
45. Al-Ahmadie HA, Alden D, Fine SW etal. Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: An ex vivo study. Am J Surg Pathol 2011; 35: 949-961.
46. Ohe C, Kuroda N, Takasu K etal. Utility of immunohistochemical analysis of KAI1, epithelial-specific antigen, and epithelial-related antigen for distinction of chromophobe renal cell carcinoma, an eosinophilic variant from renal oncocytoma. Med Mol Morphol 2012; 45: 98-104.
47. Kuroda N, Toi M, Hiroi M, Enzan H. Review of collecting duct carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 2002; 17: 1329-1334.
48. Albadine R, Schultz L, Illei P etal. PAX8(+)/p63(-) immunostaining pattern in renal collecting duct carcinoma (CDC), A useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract. Am J Surg Pathol 2010; 34: 965-969.
49. Kuroda N, Toi M, Hiroi M, Shuin T, Enzan H. Review of mucinous tubular and spindle-cell carcinoma of the kidney with a focus on clinical and pathobiological aspects. Histol Histopathol 2005; 20: 221-224.
50. Kuroda N, Toi M, Hiroi M, Shuin T, Enzan H. Review of renal oncocytoma with focus on clinical and pathobiological aspects. Histol Histopathol 2003; 18: 935-942.
51. Carvalho JC, Wasco MJ, Kinju LP, Thomas DG, Shah RB. Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C-kit(CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics. Histopathology 2011; 58: 169-179.
52. Kuroda N, Toi M, Hiroi M, Enzan H. Review of metanephric adenoma of the kidney with focus on clinical and pathobiological aspects. Histol Histopathol 2003; 18: 253-257.
53. Ozcan A, de la Roza G, Ro JY, Shen SS, Troung LD. PAX2 and PAX8 expression in primary and metastatic renal tumors. A comprehensive comparison. Arch Pathol Lab Med 2012; 136: 1541-1551.
54. Muir TE, Cheville JC, Lager DJ. Metanephric adenoma, nephrogenic rests, and Wilms' tumor. A histologic and immunophenotypic comparison. Am J Surg Pathol 2001; 25: 1290-1296.
55. Jung SJ, Chung JI, Park SH, Ayala AG, Ro JY. Thyroid follicular carcinoma-like tumor of kidney: A case report with morphologic, immunohistochemical and genetic analysis. Am J Surg Pathol 2006; 30: 411-415.
56. Amin MB, Gupta R, Hes O etal. Primary thyroid-like follicular carcinoma of the kidney: Report of 6 cases with a histologically distinctive adult renal epithelial neoplasm. Am J Surg Pathol 2009; 33: 393-400.
57. Insabato L, Ben-Dor D, Galliani CA, Lastilla G, Bisceglia M. Primary thyroid and thyroid-like follicular carcinoma of the kidney versus solitary metastatic carcinoma of the thyroid: A vexing issue. Virchows Arch 2009; 454: 717-718.
58. Dhillon J, Tannir NM, Matin SF etal. Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes. Hum Pathol 2011; 42: 146-150.